Home / Fact sheets / Uruguay / Breast qualitative data

Country fact sheet: Uruguay


Reporting year for qualitative data: 2021
Source of qualitative data: Directly from Programme

Organization of screening

An individual/team/institution responsible to coordinate the programme: No
Dedicated budget for screening programme: No
Documented cancer screening policy: Yes
Nature of documentation of the policy: Notification
Year programme was initiated: -
Programme introduction was preceded by a pilot: -
Screening tests provided free of charge: Yes
Diagnostic tests provided free of charge: No
Treatment services provided free of charge: No

Information system and data collection

System that collects data: Individual & Aggregated
   • Identification of eligible population: No
   • Screening participation: Aggregated
   • Screening test results: Individual & Aggregated
   • Further assessment: No
   • Final pathology diagnosis: Individual & Aggregated
   • Cancer staging: No
   • Treatment: Individual & Aggregated
The information system exists at national or sub-national level: Individual: National
Aggregated: National
The information system collects data outside the programme (opportunistic screening/private sector): Yes
Cancer screening data is linked with population-based cancer registry (PBCR): PBCR exists but not linked

Screening protocol

A screening protocol or guideline: Yes
Year of published/updated protocol: 2015
Target age (min-max) and screening interval [months] for each test: Mammography/DBT (50-69 years / [24 months])
All mammograms read by two radiologists independently: -

Invitations for screening and further assessment

Initiatives to create population awareness by the Health Ministry/Health Authority: Mass media campaign
Small media campaign
Group education
Dedicated website
Social media platform
Invitations to eligible population: No
Source of the eligible individuals identified: -
Method of invitation: -
Screen positive individuals actively contacted for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:

Quality Assurance (QA) of screening activities

Documented standard operating procedure/policy for QA: No
An individual/team/institution responsible for QA: No
Accreditation of mammography units: -
Accreditation of pathology services: No
Documented performance indicators: No
Reference standards for performance indicators: -
Evaluation reports published in the last five years: No

Performance indicators

Reporting year for quantitative data: 2019
Source of quantitative data: Directly from programme
Age range and regional limitation if applicable: 50-69 years
Invitation coverage (%):
Participation rate (%):
Examination coverage (%): 52.9
Completeness of data related to screening test results (%): 99.9
Completeness of data related to further assessment results (%):
Further assessment rate (%): 1.6
Further assessment participation rate (%):
Detection rate of CIS (x 1000):
Detection rate of invasive cancer (x 1000):
Detection rate of CIS and invasive cancer (x 1000):
Positive Predictive Value of abnormal screening test to detect CIS (x 1000):
Positive Predictive Value of invasive cancer (x 1000):
Positive Predictive Value of CIS and invasive cancer (x 1000):
More quantitative data (2019)

Check also the following factsheets: Uruguay, Cervical, Colorectal